Various health-related effects of long-chain (LC) ω-3 PUFAs, EPA, and DHA have been
suggested. LC ω-3 PUFAs reduce TG concentrations and have anti-inflammatory …

The residual risk for arteriosclerotic cardiovascular disease after optimal statin treatment
may amount to 50% and is the consequence of both immunological and lipid disturbances …

Background Some observational studies found that dyslipidaemia is a risk factor for non-
alcoholic fatty liver disease (NAFLD), and lipid-lowering drugs may lower NAFLD risk …

Aims The strength of the relationship of triglyceride-rich lipoproteins (TRL) with risk of
coronary heart disease (CHD) compared with low-density lipoprotein (LDL) is yet to be …

The culprits of atherosclerosis are endothelial damage, local disorders of lipid metabolism,
and progressive inflammation. Early atherosclerosis is typically difficult to diagnose in time …

Limited evidence exists on the combined and mediating effects of systemic inflammation on
the association between insulin resistance and cardiovascular events in patients with …

Triglyceride-rich lipoproteins, remnant-cholesterol, and ath... : Current Opinion in Lipidology
Triglyceride-rich lipoproteins, remnant-cholesterol, and atherosclerotic cardiovascular disease …

Context Serum levels of remnant cholesterol have been reported to predict the prognosis of
cardiovascular disease, independent of traditional lipid profiles. Objective This study aimed …

Aims/hypothesis This study explored the hypothesis that significant abnormalities in the
metabolism of intestinally derived lipoproteins are present in individuals with type 2 diabetes …

Background Conventional and unconventional lipid parameters are associated with
diabetes risk, the comparative studies on lipid parameters for predicting future diabetes risk …